Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) FCF Margin (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed FCF Margin for 6 consecutive years, with 22.16% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 11469.0% to 22.16% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 92.52% through Dec 2025, up 6975.0% year-over-year, with the annual reading at 92.52% for FY2025, 6975.0% up from the prior year.
  • FCF Margin hit 22.16% in Q4 2025 for Rapid Micro Biosystems, up from 124.19% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 22.16% in Q4 2025 to a low of 461.79% in Q2 2022.
  • Historically, FCF Margin has averaged 223.1% across 5 years, with a median of 192.28% in 2021.
  • Biggest five-year swings in FCF Margin: crashed -26526bps in 2022 and later soared 27376bps in 2023.
  • Year by year, FCF Margin stood at 292.76% in 2021, then increased by 3bps to 285.0% in 2022, then skyrocketed by 46bps to 153.64% in 2023, then rose by 11bps to 136.85% in 2024, then surged by 84bps to 22.16% in 2025.
  • Business Quant data shows FCF Margin for RPID at 22.16% in Q4 2025, 124.19% in Q3 2025, and 133.15% in Q2 2025.